Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Are antiarrhythmic drugs safe?

D Katritsis1, A J Camm

  • 1Department of Cardiological Sciences, St. George's Hospital Medical School, London, England.

Clinical Cardiology
|July 1, 1990
PubMed
Summary

Antiarrhythmic drug therapy lacks clear indications and carries risks, including potentially fatal proarrhythmic effects. Careful benefit-risk assessment is crucial before initiating treatment for severe arrhythmias.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adverse effects of amiodarone at low dose: plus ça change.

Journal of the American College of Cardiology·1997
Same author

Atrial premature beats preceding episodes of paroxysmal atrial fibrillation: factorial analysis of a prediction system.

Pacing and clinical electrophysiology : PACE·1997
Same author

Exercise-induced T-wave alternans as a marker of high risk in patients with hypertrophic cardiomyopathy.

Japanese circulation journal·1997
Same author

Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction.

Circulation·1997
Same author

Chlamydia pneumoniae and coronary heart disease.

BMJ (Clinical research ed.)·1997
Same author

Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.

Lancet (London, England)·1997

Area of Science:

  • Cardiology
  • Clinical Pharmacology

Background:

  • Indications for antiarrhythmic therapy are often unclear, leading to empiric treatment strategies.
  • Antiarrhythmic agents can cause serious, sometimes life-threatening, side effects, including proarrhythmic tendencies.

Purpose of the Study:

  • To review the challenges and risks associated with antiarrhythmic drug therapy.
  • To emphasize the importance of careful patient selection and monitoring.

Main Methods:

  • Literature review of antiarrhythmic drug indications, adverse effects, and monitoring strategies.
  • Analysis of the proarrhythmic potential of antiarrhythmic agents.

Main Results:

  • Antiarrhythmic drug use is often empirical, with significant potential for adverse effects.
  • Proarrhythmic effects, the most dangerous side effect, can be asymptomatic and detected through monitoring.
  • Monitoring can reduce, but not eliminate, proarrhythmic risk.

Conclusions:

  • Antiarrhythmic therapy should be reserved for highly symptomatic or life-threatening arrhythmias.
  • A thorough benefit-risk assessment is essential before initiating antiarrhythmic treatment.

Related Experiment Videos